ANRO (Alto Neuroscience) Other Stockholders Equity : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Stockholders Equity?

Alto Neuroscience's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $0.00 Mil.

Alto Neuroscience's quarterly Other Stockholders Equity declined from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then stayed the same from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Alto Neuroscience Other Stockholders Equity Historical Data

The historical data trend for Alto Neuroscience's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Stockholders Equity Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial						-	-	-	-	-

Alto Neuroscience Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Alto Neuroscience Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

369 South San Antonio Road, Los Altos, CA, USA, 94022

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.